Literature DB >> 15813856

Heterogeneous expression pattern of pro- and anti-apoptotic factors in myeloid progenitor cells of patients with severe congenital neutropenia treated with granulocyte colony-stimulating factor.

Gunnar Cario1, Julia Skokowa, Zheng Wang, Vesna Bucan, Cornelia Zeidler, Martin Stanulla, Martin Schrappe, Karl Welte.   

Abstract

Apoptosis is accelerated in the myeloid progenitor cells of patients with severe congenital neutropenia (CN). Granulocyte colony-stimulating factor (G-CSF) increases neutrophil numbers in most CN patients. The effect of G-CSF on apoptosis in CN was analysed by apoptosis rate and expression of anti- and pro-apoptotic factors. G-CSF-treated patients showed higher apoptosis frequency, lower expression of bcl-2 and bcl-xL, but higher expression of bfl-1/A1 and mcl-1. Caspase 9 was highly expressed in patients and controls after G-CSF administration. Thus, G-CSF acts on apoptosis regulation, but additional mechanisms leading to the increase of neutrophil numbers must be assumed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15813856     DOI: 10.1111/j.1365-2141.2005.05428.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  5 in total

Review 1.  Severe congenital neutropenias.

Authors:  Julia Skokowa; David C Dale; Ivo P Touw; Cornelia Zeidler; Karl Welte
Journal:  Nat Rev Dis Primers       Date:  2017-06-08       Impact factor: 52.329

2.  G-CSF improves murine G6PC3-deficient neutrophil function by modulating apoptosis and energy homeostasis.

Authors:  Hyun Sik Jun; Young Mok Lee; Ki Duk Song; Brian C Mansfield; Janice Y Chou
Journal:  Blood       Date:  2011-02-03       Impact factor: 22.113

3.  Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis.

Authors:  Daniel Tesfa; Tobias Gelius; Birgitta Sander; Eva Kimby; Bengt Fadeel; Jan Palmblad; Hans Hägglund
Journal:  Med Oncol       Date:  2008-02-16       Impact factor: 3.064

4.  Mutations in the ELANE gene are associated with development of periodontitis in patients with severe congenital neutropenia.

Authors:  Ying Ye; Göran Carlsson; Biniyam Wondimu; Annika Fahlén; Jenny Karlsson-Sjöberg; Mats Andersson; Lars Engstrand; Tülay Yucel-Lindberg; Thomas Modéer; Katrin Pütsep
Journal:  J Clin Immunol       Date:  2011-07-29       Impact factor: 8.317

5.  CRISPR/Cas9-mediated ELANE knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells of severe congenital neutropenia patients.

Authors:  Masoud Nasri; Malte Ritter; Perihan Mir; Benjamin Dannenmann; Narges Aghaallaei; Diana Amend; Vahagn Makaryan; Yun Xu; Breanna Fletcher; Regine Bernhard; Ingeborg Steiert; Karin Hahnel; Jürgen Berger; Iris Koch; Brigitte Sailer; Katharina Hipp; Cornelia Zeidler; Maksim Klimiankou; Baubak Bajoghli; David C Dale; Karl Welte; Julia Skokowa
Journal:  Haematologica       Date:  2019-06-27       Impact factor: 9.941

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.